EHR Data May Beat Claims Data in Assessing Sepsis Incidence

Share this content:
EHR Data May Beat Claims Data in Assessing Sepsis Incidence
EHR Data May Beat Claims Data in Assessing Sepsis Incidence

FRIDAY, Sept. 15, 2017 (HealthDay News) -- Sepsis is present in 6 percent of adult hospitalizations, with no change in incidence from 2009 to 2014 based on electronic health record (EHR) data in contrast to claims-based analyses, according to a study published online Sept. 13 in the Journal of the American Medical Association.

Chanu Rhee, M.D., M.P.H., from Harvard Medical School in Boston, and colleagues conducted a retrospective cohort study of adult patients admitted to 409 hospitals from 2009 to 2014 to estimate the national incidence of sepsis.

The researchers identified 173,690 sepsis cases using clinical criteria among 2,901,019 adults admitted to study hospitals in 2014 (6.0 percent incidence). Fifteen percent of these patients died in the hospital and 6.2 percent were discharged to hospice. Using clinical criteria, the incidence of sepsis was stable from 2009 to 2014 (+0.6 percent relative change/year), while incidence increased per claims (+10.3 percent/year). There was a decrease in in-hospital mortality using clinical criteria (−3.3 percent/year), but the combined outcome of death or discharge to hospital did not change significantly (−1.3 percent/year). Using claims, mortality declined significantly (−7.0 percent/year), as did death or discharge to hospital (−4.5 percent/year). Compared with claims, clinical criteria were more sensitive for identifying sepsis (69.7 versus 32.3 percent), with comparable positive predictive value (70.4 versus 75.2 percent).

The findings "suggest that EHR-based clinical data provide more objective estimates than claims-based data for sepsis surveillance," the authors write.

Several authors disclosed financial ties to the pharmaceutical and health care industries.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »